About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6562 record(s)
Req # A-2019-000829
Approved product labels and lists of ingredients for products, each of which was issued a Temporary Marketing Authorization (TMA) on June 12, 2019: Bang Black Cherry Vanilla Energy Drink (TMA 2018-030109); Bang Blue Razz Energy Drink (TMA 2018-…Organization: Health Canada
January 2020
Req # A-2019-000845
The documents used to support the approval of the calcitonin (salmon) injection (Drug Identification Number (DIN) 02383233) issued to Agila Specialties Private Limited (and subsequently transferred to Mylan Pharmaceuticals ULC in 2014.Organization: Health Canada
January 2020
Req # A-2019-000928
Total numbers of Licenses and total grams licensed for Individual Personal Medical Cannabis Production Licenses ( ACMPR) issued by Health Canada. In each of the communities for each of the years: 2017, 2018, 2019.Organization: Health Canada
January 2020
Req # A-2019-000521
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-106665-371.Organization: Health Canada
January 2020
Req # A-2019-000964
Any Contribution Agreements, initial or supplementary, between Health Canada and the Institute for Safe Medication Practices ("ISMP") pertaining to Health Canada's funding and ISMP's responsibilities related to the Canadian…Organization: Health Canada
January 2020
Req # A-2019-001020
Module 1 and 2 contained in the Abbreviated New Drug Submission (ANDS) that is under review with Health Canada as at September 27, 2019 for a subsequent entry product containing the medicinal ingredient cladribine.Organization: Health Canada
January 2020
Req # A-2019-001021
The name of the sponsor and the date of submission for the Abbreviated New Drug Submission (ANDS) that is under review with Health Canada as at September 27, 2019 for a subsequent entry product containing the medicinal ingredient cladribine.Organization: Health Canada
January 2020
Req # A-2019-001024
In the year 2016, letter correspondence and emails sent by Health Canada to companies and/or trade associations regarding the implementation of the Plain Language Labelling Regulations (For prescription and non-prescription drugs).Organization: Health Canada
January 2020
Req # A-2019-001025
All records between Health Canada and the Standing Joint Committee on the Scrutiny of Regulations regarding the Plain Language Labelling Regulations from Jan. 1, 2016 - Oct. 1, 2019.Organization: Health Canada
January 2020
Req # A-2019-001097
All correspondence records between Health Canada and the Author(s) of "Systematic review of the association between perineal use of talc and ovarian cancer risk" for the period January 1, 2018 -- December 31, 2018.Organization: Health Canada
January 2020